G, S., & GW, O. (2015). Thymosin beta 4 ophthalmic solution for dry eye: A randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE™) model. Dove Medical Press.
Style de citation Chicago (17e éd.)G, Sosne, et Ousler GW. Thymosin Beta 4 Ophthalmic Solution for Dry Eye: A Randomized, Placebo-controlled, Phase II Clinical Trial Conducted Using the Controlled Adverse Environment (CAE™) Model. Dove Medical Press, 2015.
Style de citation MLA (8e éd.)G, Sosne, et Ousler GW. Thymosin Beta 4 Ophthalmic Solution for Dry Eye: A Randomized, Placebo-controlled, Phase II Clinical Trial Conducted Using the Controlled Adverse Environment (CAE™) Model. Dove Medical Press, 2015.
Attention : ces citations peuvent ne pas être correctes à 100%.